As in the case of IL6, elevated circulating IL18 serum levels were found in obese and T2DM patients, reduced after weight loss and were postulated as risk predictors for metabolic syndrome development before detection of obesity and IR [250,251]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.